70719-50-5

Basic information

• Product Name: 2-bromomethyl-4,6-dimethoxy-benzoic acid methyl ester
• Synonyms: 2-bromomethyl-4,6-dimethoxy-benzoic acid methyl ester
• CAS NO: 70719-50-5
• Molecular Weight: 289.126
• Mol File: 70719-50-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-bromomethyl-4,6-dimethoxy-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromomethyl-4,6-dimethoxy-benzoic acid methyl ester(70719-50-5)
• EPA Substance Registry System: 2-bromomethyl-4,6-dimethoxy-benzoic acid methyl ester(70719-50-5)

Safety Data

• Hazardous Substances Data: 70719-50-5(Hazardous Substances Data)

Upstream product

• 6110-37-8 methyl 2,4-dimethoxy-6-methylbenzoate 
• 480-64-8 orsellinic acid 

Downstream Products

• 64095-60-9 (E)-3-methoxy-2-(3-methylbut-2-en-1-yl)-5-styrylphenol 
• 1416859-40-9 methyl 2-hydroxy-4-methoxy-6-(2-phenethyl)benzoate 
• 87402-84-4 (E)-2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)-6-styrylbenzoic acid 
• 1363155-62-7 (E)-methyl 2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)-6-styrylbenzoate 
• 1258410-99-9 (E)-2,4-dimethoxy-6-styrylbenzoic acid methyl ester 

Relevant articles and documents

Steroselective total synthesis of Neocosmosin B

-

CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE

Provided are cajanine structure analogous compounds, synthesis method and pharmacological effects thereof, the compounds of the present invention having the structure as represented by general formulas I, II, III, IV and V. Also provided are pharmaceutical compositions containing the compounds as active ingredient, and uses thereof; the compounds of the present invention having the pharmacological activities such as anti-virus, anti-virus-infection, nerve protection, anti-metabolic-diseases and the like. Also provided is a chemical total synthesis preparation method of the natural products cajanine, cajanine A and cajanine C. The present invention lays a foundation for the in-depth study and development of the compounds as clinical drugs in the future.

Aureolic Acid Antibiotics: Synthesis of Naphthocyclobutene Precursors

The use of the dianion of 1,2-dicarbomethoxycyclobutane, a method introduced by Garrett, has been exploited to produce naphthocyclobutenes with methoxy groups in the naphtho moiety.A highly regioselective functionalization of the cyclobutene ring has been